Parkinson Disease with Depression Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Parkinson Disease with Depression
Parkinson's disease (PD) is a progressive neurological disorder that primarily affects movement. However, it's widely recognized that PD also presents a range of non-motor symptoms, with depression being one of the most prevalent and impactful. Affecting up to 50% of people with Parkinson's, depression is not merely a reaction to the diagnosis but is often linked to the disease's underlying neurochemical changes, particularly in dopamine and serotonin pathways.
Living with Parkinson's-related depression can significantly diminish quality of life, exacerbating motor symptoms and increasing disability. Symptoms can include persistent sadness, loss of interest in activities, fatigue, sleep disturbances, and cognitive difficulties, which can sometimes be hard to distinguish from the PD itself. Early recognition and treatment are crucial for improving overall well-being.
Managing Parkinson's disease with depression typically involves a multi-faceted approach. For PD motor symptoms, common medications include levodopa (often combined with carbidopa), dopamine agonists like pramipexole or ropinirole, and MAO-B inhibitors such as selegiline or rasagiline. These aim to replenish dopamine levels or prevent its breakdown. For depression, specific antidepressants, often selective serotonin reuptake inhibitors (SSRIs) like sertraline or citalopram, or serotonin-norepinephrine reuptake inhibitors (SNRIs) like venlafaxine
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.